Angela Huff
Neurology · Desoto, TXNPI 1821161050
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 539 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $4,476 and has fallen 95.8% since, to $189 in 2022.
Across 539 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$2K
- Supernus Pharmaceuticals, Inc.$1K
- Acadia Pharmaceuticals Inc$830
- Sanofi$755
- Biogen$493
- MDD US Operations, LLC$485
- plus $5K from 33 others
What the payments were for
- Speaking & faculty fees$5395%
- Food & beverage$10,07995%
- Education$460%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 109 | $1,746 |
| Supernus Pharmaceuticals, Inc. | 40 | $1,160 |
| Acadia Pharmaceuticals Inc | 41 | $830 |
| Sanofi | 43 | $755 |
| Biogen | 20 | $493 |
| MDD US Operations, LLC | 23 | $485 |
| Sunovion Pharmaceuticals Inc. | 22 | $480 |
| Novartis | 28 | $473 |
| AbbVie(2 entities) | 34 | $466 |
| Teva Pharmaceuticals USA, Inc. | 20 | $394 |
| UCB, Inc. | 11 | $305 |
| Neurocrine Biosciences, Inc. | 7 | $290 |
| Lilly USA, LLC | 17 | $290 |
| Novo Nordisk | 15 | $246 |
| Biohaven Pharmaceuticals, Inc. | 13 | $216 |
| Acorda Therapeutics, Inc | 10 | $197 |
| Kyowa Kirin, Inc. | 9 | $168 |
| AstraZeneca | 4 | $152 |
| E.r. Squibb & Sons, L.L.C. | 2 | $144 |
| Johnson & Johnson | 5 | $140 |
| Genentech USA, Inc. | 8 | $131 |
| Neurelis, Inc. | 6 | $125 |
| Amgen | 3 | $123 |
| Upsher-smith Laboratories LLC | 6 | $116 |
| SK Life Science, Inc. | 6 | $98 |
| Avanir Pharmaceuticals, Inc. | 5 | $93 |
| Adamas Pharmaceuticals, Inc. | 5 | $79 |
| Lundbeck LLC | 4 | $69 |
| Alfasigma USA, Inc. | 4 | $69 |
| Arbor Pharmaceuticals, Inc. | 4 | $60 |
| Aprecia Pharmaceuticals, LLC | 4 | $59 |
| Amneal Pharmaceuticals LLC | 2 | $51 |
| GE HealthCare | 2 | $40 |
| Bristol Myers Squibb | 2 | $38 |
| Boston Scientific | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,663 in reported general payments places this provider in the 70th percentile of 1,246 neurology providers in Texas.
Other neurology in Desoto
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Mirla AvilaLubbock$1.3M
- Michael SoileauGeorgetown$1.2M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Benjamin GreenbergDallas$773K
- Annette OkaiPlano$730K
- Waleed El-FekyDallas$587K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.